Back to Treatments

Treatment

Semaglutide (GLP-1 Receptor Agonist)

1
Conditions
27
Trials
100K
Participants
60%
Average Safety

Condition Evidence

Diabetes mellitus type 2

27 trials · 100K participants

90% effectiveness · 60% safety
Semaglutide (GLP-1 Receptor Agonist) | DFDA